ACPMP - Appendix Cancer / Pseudomyxoma Peritonei Research Foundation

11/11/2025

🗳️ Voting is open for the 2nd Annual Shades of Amber: Creative Contest for a Cure!

Explore the artwork created by our community and help choose the winners. Each $5 vote supports appendix cancer research and awareness, celebrating creativity and hope along the way.

Cast your vote: https://acpmp.org/vote

Your support through Shades of Amber fuels research and patient education this season.

11/10/2025

It’s the final day to submit your artwork for the 2nd Annual Shades of Amber: Creative Contest for a Cure.

Share your creativity and help raise awareness for appendix cancer.

📅 Submit today: https://acpmp.org/event/shades-of-amber-2025/

.

11/09/2025

Artists, this is your last chance to enter!

Tomorrow is the final day to submit your artwork for the 2nd Annual Shades of Amber: Creative Contest for a Cure.

Amber represents strength, courage, and awareness for those affected by appendix cancer. Share your creativity and make an impact.

📅 Submit your art today: https://acpmp.org/event/shades-of-amber-2025/

.

11/06/2025

Oppdatering Pseudovax-studien:
Denne uken fikk den første studiepasienten sin første vaksinedose.
Dette markerer at studiet nå er over i en ny og spennende fase.
Vi ønsker Pseudovax-teamet og studiepasientene lykke til og håper at dette kan bli en ny behandling for mennesker som rammes av Pseudomyxoma Peritonei 🙏🏻

Bildet: Flatmark og Inderberg v/Radiumhospitalet

11/06/2025

💛 Give hope and get inspired all year long.

Donate $50 or more and receive a free 2026 Shades of Amber Art Calendar featuring powerful, original artwork created by our community to raise awareness for appendix cancer.

Every gift fuels research, supports patient education, and helps bring us closer to a cure.

Donate today: https://secure.acpmp.org/campaign/726529/donate

11/06/2025

A major milestone for the appendix cancer community!

National Comprehensive Cancer Network(NCCN) has released dedicated Guidelines for Appendiceal Cancer.

Read more here:

NCCN Guidelines for Appendiceal Cancer: Defining a New Standard of Care 2025 / appendiceal cancer, cancer, Cancer Management, NCCN, NCCN guidelines, NCCN

11/05/2025

Missed the live sessions from the 2025 Appendix Cancer Symposium?
Recordings are now available! Catch fundamentals education, research updates, and expert sessions at your own pace.

Watch the recordings: https://www.youtube.com/playlist?list=PLni_H1AaEnbf9qaTFadxc18-6YQudThoO

11/04/2025

Last week, the Appendix Cancer PMP Research Foundation proudly joined international colleagues at the 15th PSOGI (Peritoneal Surface Oncology Group International) Congress in Barcelona.

Our Board President, Jim Carroll, represented ACPMP on the Patient Advocate Panel for the debut of the first-ever Patient Manifesto for Peritoneal Surface Malignancies—a global initiative amplifying the voices and experiences of those living with pseudomyxoma peritonei (PMP), appendix cancer, peritoneal mesothelioma, or peritoneal metastases from gastrointestinal or gynecological cancers.

In addition, Dr. Andreana Holowatyj, Chair of ACPMP’s Scientific Advisory Board, presented findings from the ACPMP-sponsored Scientific Think Tank, recently featured in Nature Reviews Cancer earlier this year. Her presentation highlighted the first-ever research roadmap to advance treatment for appendix cancer, marking a major milestone for the field.

ACPMP also hosted an exhibit booth and connected with global leaders in research and advocacy throughout the conference. We’re honored to be part of this historic initiative alongside Asociación Peritoneum (Spain), Pseudomyxoma Survivoror (UK), PMP Pals Appendix Cancer Network (USA), Association contre les maladies rares du péritoine (France), Mesothelioma UK, and Pmp contactgroepoep (Netherlands). We're all working together to elevate awareness, advocate for equitable care, and shape the future of peritoneal cancer treatment and research.

11/01/2025

Ready to make a difference through your art?

Enter the 2nd Annual Shades of Amber: Creative Contest for a Cure and help support appendix cancer research, education, and awareness.

Prizes:
🥇 $300
🥈 $200
🥉 $100
Plus, the top 12 artworks will be featured in our 2027 calendar!

Submission deadline: November 10, 2025
Submit your artwork: https://acpmp.org/event/shades-of-amber-2025/

This Giving Tuesday, join us in the fight against appendix cancer. Every donation makes a difference! https://secure.acpmp.org/shades-of-amber-2025

10/31/2025

🌟 Your voice matters! If our foundation has made a difference for you, please share your experience.

Help us maintain our 2025 Top Nonprofits Badge by leaving a review on our Great Nonprofits profile: https://greatnonprofits.org/org/appendix-cancer-pseudomyxoma-peritonei-research-foundation-acpmp

📅 Submit by December 31, 2025

10/29/2025

Eating well during cancer treatment can be challenging.

In this interview with CURE Today, registered dietitian Kanisha Parikh from John Theurer Cancer Center shares practical tips for maintaining nutrition when eating becomes difficult.

🎧 Listen or read the full interview from CURE: “Eating Tips for When Cancer Treatment Makes Meals Challenging.”

Hackensack Meridian Health

Greek yogurt, egg salad, avocado and mac and cheese are easy-to-swallow, high-calorie foods that can help patients maintain strength during cancer treatment.

10/24/2025

🌍 The voice of patients at

On October 30th in Barcelona, during the International PSOGI 2025 Congress, a very special moment will take place: the official reading and presentation of the Patient Manifesto on Peritoneal Malignancies.

Six representatives from patient associations in Spain, the United Kingdom, France, and the United States will come together to share one united voice; highlighting the needs, challenges, and hopes of those living with these diseases.

Their participation underscores the importance of listening to, involving, and empowering patients in research, treatment, and comprehensive care.

In the photo: the representatives who will deliver this meaningful message during the patient session of the congress.